Pharming Group N.V. (PHAR)
USD 7.69
(0.52%)
USD 7.69
(0.52%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 109.8 Million USD | 370.13% |
| 2022 | -40.64 Million USD | -34.9% |
| 2021 | -30.13 Million EUR | 30.36% |
| 2020 | -43.26 Million EUR | -168.25% |
| 2019 | -16.13 Million EUR | -91.02% |
| 2018 | -8.44 Million EUR | -131.09% |
| 2017 | 27.16 Million EUR | -27.25% |
| 2016 | 37.33 Million EUR | 316.46% |
| 2015 | -17.25 Million EUR | 56.48% |
| 2014 | -39.63 Million EUR | -91.41% |
| 2013 | -20.7 Million EUR | -547.78% |
| 2012 | -3.19 Million EUR | -616.94% |
| 2011 | -445.85 Thousand EUR | 96.75% |
| 2010 | -13.7 Million EUR | -171.55% |
| 2009 | 19.15 Million EUR | -24.23% |
| 2008 | 25.27 Million EUR | 149.2% |
| 2007 | -51.37 Million EUR | -58.86% |
| 2006 | -32.33 Million EUR | -88.3% |
| 2005 | -17.17 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 85.97 Million USD | -25.45% |
| 2024 Q3 | 34.75 Million USD | -22.74% |
| 2024 Q1 | 115.31 Million USD | 5.02% |
| 2023 Q3 | 109.33 Million USD | 591.62% |
| 2023 Q4 | 109.8 Million USD | 0.43% |
| 2023 FY | 109.8 Million USD | 370.13% |
| 2023 Q1 | -14.38 Million USD | 64.62% |
| 2023 Q2 | -22.23 Million USD | -54.64% |
| 2022 Q1 | -31.88 Million USD | -19.81% |
| 2022 Q2 | -40.96 Million USD | -28.46% |
| 2022 Q3 | -49.52 Million USD | -20.89% |
| 2022 Q4 | -40.64 Million USD | 17.92% |
| 2022 FY | -40.64 Million USD | -34.9% |
| 2021 Q1 | -52.64 Million EUR | -21.68% |
| 2021 FY | -30.13 Million EUR | 30.36% |
| 2021 Q4 | -26.61 Million EUR | -43.7% |
| 2021 Q3 | -18.52 Million EUR | -3.33% |
| 2021 Q2 | -17.92 Million EUR | 65.96% |
| 2020 Q1 | -7.24 Million EUR | 55.06% |
| 2020 Q4 | -43.26 Million EUR | -48.86% |
| 2020 Q3 | -29.06 Million EUR | -8.23% |
| 2020 FY | -43.26 Million EUR | -168.25% |
| 2020 Q2 | -26.85 Million EUR | -270.46% |
| 2019 Q3 | -2.65 Million EUR | -234.85% |
| 2019 Q4 | -16.13 Million EUR | -508.46% |
| 2019 Q2 | 1.96 Million EUR | -71.77% |
| 2019 FY | -16.13 Million EUR | -91.02% |
| 2019 Q1 | 6.96 Million EUR | 182.47% |
| 2018 FY | -8.44 Million EUR | -131.09% |
| 2018 Q4 | -8.44 Million EUR | -207.2% |
| 2018 Q3 | 7.87 Million EUR | -62.16% |
| 2018 Q2 | 20.81 Million EUR | -16.15% |
| 2018 Q1 | 24.82 Million EUR | -8.6% |
| 2017 Q3 | 58.77 Million EUR | -21.56% |
| 2017 Q4 | 27.16 Million EUR | -53.78% |
| 2017 Q2 | 74.92 Million EUR | 83.39% |
| 2017 Q1 | 40.85 Million EUR | 9.42% |
| 2017 FY | 27.16 Million EUR | -27.25% |
| 2016 Q2 | -6.12 Million EUR | 55.35% |
| 2016 FY | 37.33 Million EUR | 316.46% |
| 2016 Q4 | 37.33 Million EUR | 2324.8% |
| 2016 Q3 | -1.67 Million EUR | 72.58% |
| 2016 Q1 | -13.7 Million EUR | 20.54% |
| 2015 FY | -17.25 Million EUR | 56.48% |
| 2015 Q3 | -20.83 Million EUR | 21.51% |
| 2015 Q4 | -17.25 Million EUR | 17.22% |
| 2015 Q1 | -31.3 Million EUR | 21.02% |
| 2015 Q2 | -26.54 Million EUR | 15.19% |
| 2014 FY | -39.63 Million EUR | -91.41% |
| 2014 Q4 | -39.63 Million EUR | -41.37% |
| 2014 Q3 | -28.03 Million EUR | 16.44% |
| 2014 Q2 | -33.55 Million EUR | -43.72% |
| 2014 Q1 | -23.34 Million EUR | -12.75% |
| 2013 Q3 | -10.62 Million EUR | -103.11% |
| 2013 FY | -20.7 Million EUR | -547.78% |
| 2013 Q1 | -7.38 Million EUR | -130.88% |
| 2013 Q2 | -5.23 Million EUR | 29.12% |
| 2013 Q4 | -20.7 Million EUR | -94.88% |
| 2012 Q1 | -2.29 Million EUR | -415.82% |
| 2012 Q4 | -3.19 Million EUR | -255.88% |
| 2012 Q3 | 2.05 Million EUR | 0.0% |
| 2012 FY | -3.19 Million EUR | -616.94% |
| 2011 Q3 | -11.85 Million EUR | 17.29% |
| 2011 Q4 | -445.85 Thousand EUR | 96.24% |
| 2011 FY | -445.85 Thousand EUR | 96.75% |
| 2011 Q1 | -20.45 Million EUR | -50.38% |
| 2011 Q2 | -14.33 Million EUR | 29.88% |
| 2010 FY | -13.7 Million EUR | -171.55% |
| 2010 Q2 | 2.45 Million EUR | -87.77% |
| 2010 Q1 | 20.08 Million EUR | 4.86% |
| 2010 Q3 | -7.74 Million EUR | -415.45% |
| 2010 Q4 | -13.59 Million EUR | -75.49% |
| 2009 FY | 19.15 Million EUR | -24.23% |
| 2009 Q4 | 19.15 Million EUR | 0.0% |
| 2008 FY | 25.27 Million EUR | 149.2% |
| 2007 FY | -51.37 Million EUR | -58.86% |
| 2006 FY | -32.33 Million EUR | -88.3% |
| 2005 FY | -17.17 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | 296.289% |
| Alkermes plc | -166.73 Million USD | 165.854% |
| Agenus Inc. | 274.13 Million USD | 59.945% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 94.128% |
| Aptorum Group Limited | 1.35 Million USD | -7991.399% |
| Ardelyx, Inc. | 34.51 Million USD | -218.162% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | -2465.514% |
| Bicycle Therapeutics plc | -481.46 Million USD | 122.806% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | -203.636% |
| ChromaDex Corporation | -24.04 Million USD | 556.603% |
| Chimerix, Inc. | -25.51 Million USD | 530.317% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | -1475.815% |
| Caribou Biosciences, Inc. | -23.67 Million USD | 563.758% |
| CRISPR Therapeutics AG | -150.84 Million USD | 172.793% |
| Precision BioSciences, Inc. | -85.41 Million USD | 228.561% |
| Dyadic International, Inc. | -6.37 Million USD | 1821.579% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | 789.161% |
| Fortress Biotech, Inc. | 7.66 Million USD | -1332.538% |
| Lantern Pharma Inc. | -21.7 Million USD | 605.933% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 199.337% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | 1385.283% |
| Incyte Corporation | -3.17 Billion USD | 103.458% |
| IO Biotech, Inc. | -140.69 Million USD | 178.042% |
| Jaguar Health, Inc. | 29.39 Million USD | -273.597% |
| Novavax, Inc. | -298.29 Million USD | 136.811% |
| Janux Therapeutics, Inc. | 5.33 Million USD | -1957.411% |
| Opthea Limited | 28.15 Million USD | -289.964% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | 754.023% |
| ContextLogic Inc. | -232 Million USD | 147.329% |
| MiMedx Group, Inc. | -33.9 Million USD | 423.896% |
| Pyxis Oncology, Inc. | 10.19 Million USD | -977.038% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | 4839.004% |
| NextCure, Inc. | -6.47 Million USD | 1795.291% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | 317.429% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | 1821.336% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | -802.751% |
| Vaxcyte, Inc. | -368.22 Million USD | 129.82% |
| PDS Biotechnology Corporation | -32.7 Million USD | 435.701% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | -535.513% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | 731.203% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 162.663% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 692.899% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 692.899% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | 1646.535% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | 1973.788% |
| Acelyrin, Inc. | -216.9 Million USD | 150.624% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | 2057.197% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | 6469.142% |
| Summit Therapeutics Inc. | 34.67 Million USD | -216.675% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | 1714.053% |
| Senti Biosciences, Inc. | 1.74 Million USD | -6210.575% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 159.48% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 241.772% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | 1911.349% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | -109958.235% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | -17384.713% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 193.813% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 165.269% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 0.961% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | 1545.55% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 185.044% |
| Psyence Biomedical Ltd. | 6.89 Million USD | -1492.609% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 145.306% |
| Immix Biopharma, Inc. | -17.5 Million USD | 727.101% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 134.671% |
| MEI Pharma, Inc. | -3.7 Million USD | 3063.671% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | -777.66% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 32.112% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | -295.078% |
| Fortress Biotech, Inc. | 7.66 Million USD | -1332.538% |
| Precigen, Inc. | -481 Thousand USD | 22928.274% |
| Clearside Biomedical, Inc. | 14.08 Million USD | -679.803% |
| AlloVir, Inc. | -62.69 Million USD | 275.148% |
| C4 Therapeutics, Inc. | -55.61 Million USD | 297.439% |
| Fate Therapeutics, Inc. | 61.66 Million USD | -78.062% |
| ImmuCell Corporation | 10.99 Million USD | -899.075% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 171.234% |
| Onconetix, Inc. | 5.33 Million USD | -1959.557% |
| PureTech Health plc | -167.19 Million USD | 165.673% |
| VYNE Therapeutics Inc. | -30.46 Million USD | 460.486% |
| Elevation Oncology, Inc. | -19.11 Million USD | 674.349% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | 2336.79% |
| Seer, Inc. | -4.24 Million USD | 2689.717% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | 556.812% |
| Innoviva, Inc. | 255.56 Million USD | 57.034% |
| Aadi Bioscience, Inc. | -55.86 Million USD | 296.556% |
| ESSA Pharma Inc. | -33.62 Million USD | 426.588% |
| GlycoMimetics, Inc. | -40.98 Million USD | 367.916% |
| GT Biopharma, Inc. | -1.02 Million USD | 10854.554% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 261.993% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | -79.251% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 181.895% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | 892.465% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | 480.313% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | 145856.232% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | 455.79% |
| Aptose Biosciences Inc. | -8.19 Million USD | 1439.914% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | 3609.216% |
| Soligenix, Inc. | -4.95 Million USD | 2317.547% |
| Century Therapeutics, Inc. | 847 Thousand USD | -12863.872% |
| Kura Oncology, Inc. | -20.11 Million USD | 645.8% |
| TScan Therapeutics, Inc. | -40.92 Million USD | 368.299% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | 1407.502% |
| Ocean Biomedical, Inc. | 1.82 Million USD | -5927.573% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | 3534.595% |
| Autolus Therapeutics plc | -186.59 Million USD | 158.845% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | 322.708% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 139.814% |
| Eterna Therapeutics Inc. | 34.26 Million USD | -220.427% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 33.196% |
| GRI Bio, Inc. | -1.79 Million USD | 6220.624% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | 1322.347% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | 430.168% |
| IGM Biosciences, Inc. | -72.6 Million USD | 251.233% |
| INmune Bio, Inc. | -25.41 Million USD | 532.112% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 27.259% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 316.751% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 775.743% |
| Entero Therapeutics, Inc. | -2.88 Million USD | 3906.129% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | -188.844% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | 366.612% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | -244.375% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 70.948% |
| Verastem, Inc. | -37.27 Million USD | 394.554% |
| Abeona Therapeutics Inc. | -9.07 Million USD | 1310.228% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | 311.723% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | 825.497% |
| Histogen Inc. | -7.48 Million USD | 1566.595% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | 608.191% |
| Surrozen, Inc. | -32.66 Million USD | 436.162% |
| Organovo Holdings, Inc. | -1.5 Million USD | 7386.264% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 2712.212% |
| Ovid Therapeutics Inc. | 18.96 Million USD | -479.129% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | -4097.401% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | -2542.06% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | 1410.13% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | 352.76% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | 853.276% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 134.662% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | 15307.047% |
| Apollomics, Inc. | -27.39 Million USD | 500.818% |
| Amarin Corporation plc | -191.04 Million USD | 157.477% |
| Mesoblast Limited | 55.96 Million USD | -96.208% |
| Turnstone Biologics Corp. | -14.58 Million USD | 852.907% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | 534.145% |
| Synaptogenix, Inc. | -28.66 Million USD | 483.106% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | 11831.197% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | -125.322% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 12836.968% |
| Monopar Therapeutics Inc. | -7.26 Million USD | 1611.186% |
| Exelixis, Inc. | -73.05 Million USD | 250.313% |
| Better Therapeutics, Inc. | -860 Thousand USD | 12867.907% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | 557.269% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 145.492% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -14817.684% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | 1576.23% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | -8656.3% |
| Gritstone bio, Inc. | 39.49 Million USD | -178.055% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 230.562% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | 4271.663% |
| Avid Bioservices, Inc. | 169.72 Million USD | 35.306% |
| Insmed Incorporated | 721.62 Million USD | 84.784% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | 1301.158% |
| MediWound Ltd. | -5.32 Million USD | 2163.209% |
| OmniAb, Inc. | 9.2 Million USD | -1093.133% |
| Alector, Inc. | -35.63 Million USD | 408.118% |
| Seres Therapeutics, Inc. | 85.97 Million USD | -27.722% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | 2328.166% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | -729.398% |
| Zai Lab Limited | -775 Million USD | 114.168% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 67.757% |
| Aura Biosciences, Inc. | -21.52 Million USD | 610.123% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 233.128% |
| Immunic, Inc. | -45.34 Million USD | 342.179% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 156.83% |
| Veracyte, Inc. | -203.82 Million USD | 153.872% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 82.797% |
| FibroGen, Inc. | 56.76 Million USD | -93.429% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -1133.06% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | 3984.005% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | 5403.649% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 97.608% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | 3386.561% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 166.161% |
| TG Therapeutics, Inc. | 17.86 Million USD | -514.735% |
| Galecto, Inc. | -21.21 Million USD | 617.553% |
| Calithera Biosciences, Inc. | -23.78 Million USD | 561.652% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 93.003% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | 548.692% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | 1054.237% |
| XBiotech Inc. | -200.02 Million USD | 154.896% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 230.562% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | -2325.0% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | 411.386% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 242.2% |
| Theravance Biopharma, Inc. | 5.69 Million USD | -1829.432% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 164.433% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 218.869% |
| Vaxxinity, Inc. | 10.13 Million USD | -983.735% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 85.086% |
| Gain Therapeutics, Inc. | -10.76 Million USD | 1119.768% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | 266.481% |
| NexImmune, Inc. | -3.13 Million USD | 3604.037% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | 3280.261% |
| Marker Therapeutics, Inc. | -15.11 Million USD | 826.628% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | 505.181% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | 1323.299% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | 88242.886% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | 370.64% |
| Ainos, Inc. | 4.07 Million USD | -2592.642% |
| Pluri Inc. | 22.82 Million USD | -380.985% |
| Prothena Corporation plc | -608.34 Million USD | 118.05% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 192.462% |
| Celularity Inc. | 65.19 Million USD | -68.437% |
| Rallybio Corporation | -24.1 Million USD | 555.58% |
| Cue Biopharma, Inc. | -33.81 Million USD | 424.681% |
| MeiraGTx Holdings plc | -40.3 Million USD | 372.453% |
| Omeros Corporation | 331.17 Million USD | 66.844% |
| Humacyte, Inc. | -22.48 Million USD | 588.322% |
| Immunocore Holdings plc | -358.59 Million USD | 130.621% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | 546.812% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | 455.341% |
| Blueprint Medicines Corporation | 702.83 Million USD | 84.377% |
| CalciMedica, Inc. | -5.53 Million USD | 2085.606% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 158.338% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | 1175.034% |
| Scholar Rock Holding Corporation | -40.03 Million USD | 374.256% |
| Sana Biotechnology, Inc. | -33.25 Million USD | 430.208% |
| Pulmatrix, Inc. | -10.41 Million USD | 1154.085% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | 1937.109% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | 387.882% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 198.566% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | 283.178% |
| Cytokinetics, Incorporated | 642.37 Million USD | 82.906% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | 1985.695% |
| Nutriband Inc. | -251.65 Thousand USD | 43732.404% |
| Protara Therapeutics, Inc. | -34.11 Million USD | 421.827% |
| Vor Biopharma Inc. | 4.3 Million USD | -2453.581% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 101.819% |
| Evogene Ltd. | -19.63 Million USD | 659.254% |
| ProKidney Corp. | -56.23 Million USD | 295.256% |
| Applied Therapeutics, Inc. | -48.67 Million USD | 325.6% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | 1288.717% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 91.949% |
| CorMedix Inc. | -43.05 Million USD | 355.047% |
| BioLineRx Ltd. | 7.33 Million USD | -1396.783% |
| Tango Therapeutics, Inc. | -27.46 Million USD | 499.796% |
| Galectin Therapeutics Inc. | 46.14 Million USD | -137.944% |
| Atai Life Sciences N.V. | -28.55 Million USD | 484.495% |
| Renovaro Biosciences Inc. | 2.23 Million USD | -4822.778% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | 581.259% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | -519.137% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 246.261% |
| MediciNova, Inc. | -50.78 Million USD | 316.22% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 239.336% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 488226.25% |
| GeoVax Labs, Inc. | -6.45 Million USD | 1801.705% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 154.951% |
| Biomea Fusion, Inc. | -166.57 Million USD | 165.921% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 161.352% |
| Mereo BioPharma Group plc | -51.46 Million USD | 313.34% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 215.773% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 137.379% |
| Absci Corporation | -72.59 Million USD | 251.249% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -2304.818% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 146.837% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 216.551% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 214.743% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | 381.023% |
| Allakos Inc. | -24.97 Million USD | 539.656% |
| Imunon, Inc. | -4.21 Million USD | 2705.787% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | 844.838% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 181.096% |
| BioAtla, Inc. | -109.01 Million USD | 200.727% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -14817.684% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | 11793.717% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | -817.633% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | 617.87% |
| XOMA Corporation | -29 Million USD | 478.634% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | 763.068% |
| Cara Therapeutics, Inc. | -9.01 Million USD | 1317.879% |
| aTyr Pharma, Inc. | -7.44 Million USD | 1574.077% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 188.1% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 152.749% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 234.269% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 218.37% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | 12880.033% |
| Akari Therapeutics, Plc | -3.84 Million USD | 2955.761% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -6665.955% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 92.048% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 9341.711% |
| UroGen Pharma Ltd. | 4.39 Million USD | -2400.66% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 3.24% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | -152486.087% |
| Orgenesis Inc. | 21.78 Million USD | -404.058% |
| Entera Bio Ltd. | -10.62 Million USD | 1133.06% |
| GH Research PLC | -78.07 Million USD | 240.636% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | 592.66% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | 511.883% |
| Xencor, Inc. | 29.64 Million USD | -270.409% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | 5674.339% |
| Replimune Group, Inc. | 1.41 Million USD | -7676.487% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | 44934.795% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 186.859% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 9341.711% |
| Portage Biotech Inc. | -4.98 Million USD | 2304.457% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 488226.25% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 266.063% |
| OncoCyte Corporation | -6.56 Million USD | 1773.076% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | -12135.615% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | 2510.285% |
| Purple Biotech Ltd. | -14.13 Million USD | 876.659% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | 562.216% |
| scPharmaceuticals Inc. | -6.54 Million USD | 1777.678% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | 757.818% |
| HilleVax, Inc. | -165.48 Million USD | 166.353% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | 4426.399% |
| Tharimmune, Inc. | -10.93 Million USD | 1104.119% |
| Genprex, Inc. | -6.73 Million USD | 1729.713% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 129.773% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 224.128% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | 7937.545% |
| Virios Therapeutics, Inc. | -3.31 Million USD | 3410.395% |
| OKYO Pharma Limited | -826.84 Thousand USD | 13379.829% |
| Savara Inc. | 153 Thousand USD | -71667.32% |
| Curis, Inc. | -23.88 Million USD | 559.681% |
| Daré Bioscience, Inc. | -5.15 Million USD | 2228.846% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | 14249.781% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | 1868.75% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | -9166.16% |
| BeiGene, Ltd. | -2.25 Billion USD | 104.873% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | -789.93% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 118.054% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 159.166% |
| Erasca, Inc. | -37.21 Million USD | 395.045% |
| bluebird bio, Inc. | 108.57 Million USD | -1.136% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 8625.864% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 71.009% |
| DBV Technologies S.A. | -126.98 Million USD | 186.469% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 8625.864% |
| Moderna, Inc. | -2.9 Billion USD | 103.777% |
| Vincerx Pharma, Inc. | -10.35 Million USD | 1160.703% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | 1110.342% |
| Molecular Templates, Inc. | 707 Thousand USD | -15430.976% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | 450.018% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 68.32% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 233.806% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 219.703% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | 440.245% |
| Cogent Biosciences, Inc. | -34.37 Million USD | 419.421% |
| MacroGenics, Inc. | -66.98 Million USD | 263.923% |
| RenovoRx, Inc. | -1.17 Million USD | 9460.955% |
| Adicet Bio, Inc. | -138.78 Million USD | 179.117% |
| Prime Medicine, Inc. | -27.94 Million USD | 492.985% |
| Aditxt, Inc. | 18.12 Million USD | -505.953% |
| Adagene Inc. | -87.62 Million USD | 225.308% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 2736.08% |
| Quantum-Si incorporated | -118.55 Million USD | 192.617% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | -204.969% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | 1569.109% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | 326.358% |
| SciSparc Ltd. | -2.06 Million USD | 5417.385% |
| Vericel Corporation | 1.27 Million USD | -8498.59% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 1015.667% |
| Minerva Neurosciences, Inc. | 41 Million USD | -167.787% |
| Generation Bio Co. | 31.44 Million USD | -249.161% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 162.615% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | 455.088% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 5.823% |
| Invivyd, Inc. | -198.47 Million USD | 155.324% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 221.64% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | 4679.578% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 255.112% |
| Artelo Biosciences, Inc. | -6.82 Million USD | 1708.85% |
| 2seventy bio, Inc. | 181.71 Million USD | 39.574% |
| ADMA Biologics, Inc. | 90.06 Million USD | -21.915% |
| Clene Inc. | 3.34 Million USD | -3187.545% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | 1308.935% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | 610.455% |
| GeoVax Labs, Inc. | -6.45 Million USD | 1801.705% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 131.908% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | 522.328% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 38.196% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | 2783.666% |
| Finch Therapeutics Group, Inc. | 5 Million USD | -2095.202% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | 2207.967% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 184.268% |
| Evaxion Biotech A/S | 5.28 Million USD | -1976.929% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 197.545% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 183.646% |
| Trevena, Inc. | 2.25 Million USD | -4762.888% |
| Surrozen, Inc. | -32.66 Million USD | 436.162% |
| Tyra Biosciences, Inc. | -51.51 Million USD | 313.17% |
| Cingulate Inc. | 3.08 Million USD | -3461.962% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | 3838.645% |
| Unity Biotechnology, Inc. | 7.18 Million USD | -1427.814% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | 1281.803% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 238.426% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 183.532% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 204.038% |
| Clearmind Medicine Inc. | -3.94 Million USD | 2885.04% |
| Kronos Bio, Inc. | -36.05 Million USD | 404.554% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | -1067.01% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -7430.483% |
| Viking Therapeutics, Inc. | -54.25 Million USD | 302.381% |
| Statera Biopharma, Inc. | 14.41 Million USD | -661.66% |
| ImmunityBio, Inc. | 618.22 Million USD | 82.239% |
| Korro Bio, Inc. | -132.94 Million USD | 182.595% |
| Kineta, Inc. | -4.54 Million USD | 2518.058% |
| BioVie Inc. | -17.73 Million USD | 719.23% |
| Codexis, Inc. | -43.27 Million USD | 353.759% |
| Celularity Inc. | 65.19 Million USD | -68.437% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | 3564.942% |
| Celcuity Inc. | 6.78 Million USD | -1518.69% |
| Virax Biolabs Group Limited | -3.36 Million USD | 3363.175% |
| Cibus, Inc. | -8.07 Million USD | 1459.297% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | 2696.453% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | -2302.713% |
| IN8bio, Inc. | -16.38 Million USD | 769.986% |
| Kodiak Sciences Inc. | -103.87 Million USD | 205.708% |
| Annexon, Inc. | -193.75 Million USD | 156.672% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | -304911.111% |
| Assembly Biosciences, Inc. | -17.49 Million USD | 727.487% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | 3225.648% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 89.585% |
| Eyenovia, Inc. | 1.25 Million USD | -8623.59% |
| Puma Biotechnology, Inc. | 26.9 Million USD | -308.117% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 3485.877% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | 430.267% |
| Arcellx, Inc. | -296.95 Million USD | 136.976% |
| Cardiff Oncology, Inc. | -19.5 Million USD | 662.924% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | 286.504% |
| Regulus Therapeutics Inc. | -20.72 Million USD | 629.763% |
| Moolec Science SA | 117.61 Thousand USD | -93258.047% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | 385.955% |
| Geron Corporation | 14.76 Million USD | -643.879% |
| LAVA Therapeutics N.V. | -37.91 Million USD | 389.583% |
| Royalty Pharma plc | 5.65 Billion USD | 98.059% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 177.643% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | 1671.002% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | 2147.49% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 178.024% |
| Humacyte, Inc. | -22.48 Million USD | 588.322% |
| Structure Therapeutics Inc. | -124.33 Million USD | 188.31% |
| 89bio, Inc. | -289.05 Million USD | 137.987% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | 535.005% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | 6258.385% |
| Genelux Corporation | -6.89 Million USD | 1691.593% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | 453.534% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | -31.346% |
| Notable Labs, Ltd. | -9.77 Million USD | 1223.2% |
| Liquidia Corporation | -80.17 Million USD | 236.954% |
| Mustang Bio, Inc. | -3.73 Million USD | 3039.079% |
| Immunovant, Inc. | -635.22 Million USD | 117.286% |
| Quantum-Si incorporated | -118.55 Million USD | 192.617% |
| Arbutus Biopharma Corporation | -17.56 Million USD | 725.165% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | 2750.35% |
| Vera Therapeutics, Inc. | 8.02 Million USD | -1267.933% |
| Acasti Pharma Inc. | -23 Million USD | 577.305% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | 3360.96% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 775.743% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 179.718% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | 3623.467% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | 593.901% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | 691.33% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 164.866% |
| PepGen Inc. | -60.67 Million USD | 280.986% |
| Moleculin Biotech, Inc. | -22.97 Million USD | 577.907% |
| United Therapeutics Corporation | -507.7 Million USD | 121.628% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | 674.109% |
| Solid Biosciences Inc. | -47.75 Million USD | 329.956% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 12836.968% |
| Immuneering Corporation | -54.94 Million USD | 299.851% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 2712.212% |
| Silo Pharma, Inc. | -3.52 Million USD | 3215.619% |
| Belite Bio, Inc | -87.27 Million USD | 225.82% |
| XOMA Corporation | -29 Million USD | 478.634% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 255.316% |
| Bionomics Limited | 227 Million USD | 51.63% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 194.429% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 4434.939% |
| uniQure N.V. | -102.95 Million USD | 206.657% |
| Cassava Sciences, Inc. | -121.13 Million USD | 190.645% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 2736.08% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | -168.135% |
| Forte Biosciences, Inc. | -11.96 Million USD | 1018.017% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | 3648.704% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | -103488.679% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 3485.877% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -1133.06% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | 1580.636% |
| Altimmune, Inc. | -134.48 Million USD | 181.647% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 44.562% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 4434.939% |
| Compugen Ltd. | -12.9 Million USD | 950.93% |
| Peak Bio, Inc. | 10.34 Million USD | -961.918% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | 38900.0% |
| Benitec Biopharma Inc. | -50.58 Million USD | 317.081% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 205.239% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | -458.941% |
| Zura Bio Limited | -99.8 Million USD | 210.017% |
| PolyPid Ltd. | 6.17 Million USD | -1679.643% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | -48.144% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | -458.941% |
| Instil Bio, Inc. | 75.35 Million USD | -45.71% |
| argenx SE | -2.02 Billion USD | 105.412% |
| Immunome, Inc. | -97.02 Million USD | 213.166% |
| Compass Therapeutics, Inc. | -22.49 Million USD | 588.126% |
| Verona Pharma plc | -220.44 Million USD | 149.811% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 253.052% |
| Shattuck Labs, Inc. | -121.42 Million USD | 190.43% |
| CervoMed Inc. | -7.79 Million USD | 1509.036% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 159.194% |
| Plus Therapeutics, Inc. | -4.37 Million USD | 2610.954% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 183.349% |
| Moolec Science SA | 117.61 Thousand USD | -93258.047% |
| Enveric Biosciences, Inc. | -2.28 Million USD | 4899.174% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | -590.662% |
| AnaptysBio, Inc. | -18.15 Million USD | 704.947% |
| Design Therapeutics, Inc. | -18.15 Million USD | 704.981% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 256.014% |
| NeurAxis, Inc. | 145.7 Thousand USD | -75263.075% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | -877.6% |
| Lumos Pharma, Inc. | -28.49 Million USD | 485.372% |
| Achilles Therapeutics plc | -126.92 Million USD | 186.512% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 253.052% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | 16845.307% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | 628.569% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -7430.483% |
| Nutriband Inc. | -251.65 Thousand USD | 43732.404% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | 933.68% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | 1575.86% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 67.723% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | -362.625% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 124.539% |
| Palisade Bio, Inc. | -12.06 Million USD | 1010.254% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 178.258% |
| Beam Therapeutics Inc. | -262.72 Million USD | 141.795% |
| Neurogene Inc. | -131.95 Million USD | 183.213% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | -403.319% |
| AEON Biopharma, Inc. | -4.88 Million USD | 2350.082% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 129.111% |
| Sesen Bio, Inc. | -112.55 Million USD | 197.558% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 209.958% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | 4776.903% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | 381.361% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 231.846% |
| Athira Pharma, Inc. | -88.99 Million USD | 223.377% |
| Vaccinex, Inc. | -1.28 Million USD | 8625.155% |
| HCW Biologics Inc. | 2.85 Million USD | -3743.768% |
| XOMA Corporation | -29 Million USD | 478.634% |
| Nektar Therapeutics | 210.24 Million USD | 47.772% |
| Arvinas, Inc. | -313.8 Million USD | 134.992% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -6665.955% |
| Merus N.V. | -192.88 Million USD | 156.927% |
| Omega Therapeutics, Inc. | 59.98 Million USD | -83.052% |
| Quince Therapeutics, Inc. | -6.93 Million USD | 1682.646% |
| Rezolute, Inc. | -68.16 Million USD | 261.079% |
| Clene Inc. | 3.34 Million USD | -3187.545% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | 932.669% |
| BeyondSpring Inc. | -13.75 Million USD | 898.284% |
| Synlogic, Inc. | -6.68 Million USD | 1742.543% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | -9582.892% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | 1398.687% |
| Peak Bio, Inc. | 10.34 Million USD | -961.918% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 233.225% |
| Krystal Biotech, Inc. | -350.23 Million USD | 131.352% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 11.538% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 164.974% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | 3577.953% |
| MannKind Corporation | 143.89 Million USD | 23.694% |
| Ikena Oncology, Inc. | -109.15 Million USD | 200.594% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | 1550.324% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | 431.734% |
| Gossamer Bio, Inc. | 180.35 Million USD | 39.118% |
| CohBar, Inc. | -5.93 Million USD | 1951.441% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | 469.114% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -2304.818% |
| Legend Biotech Corporation | -949.39 Million USD | 111.566% |
| Mural Oncology plc | -255.84 Million USD | 142.919% |
| Biora Therapeutics, Inc. | 32.21 Million USD | -240.847% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | 2430.977% |
| Disc Medicine, Inc. | -358.28 Million USD | 130.647% |
| Champions Oncology, Inc. | 4.81 Million USD | -2181.879% |
| REGENXBIO Inc. | 54.76 Million USD | -100.489% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | 40933.448% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 172.706% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | 1318.419% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 236.093% |
| Vaxart, Inc. | -8.24 Million USD | 1432.411% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | 318.82% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 186.347% |
| Cellectis S.A. | -43.85 Million USD | 350.38% |
| Longeveron Inc. | -2.9 Million USD | 3875.928% |
| Repare Therapeutics Inc. | -107.85 Million USD | 201.804% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 88.661% |
| Inozyme Pharma, Inc. | 12 Million USD | -814.728% |
| Revolution Medicines, Inc. | -608.2 Million USD | 118.054% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | 9027.154% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 141.417% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 173.168% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | 801.758% |
| Anixa Biosciences, Inc. | -740 Thousand USD | 14938.378% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 101.148% |
| Denali Therapeutics Inc. | -74.86 Million USD | 246.669% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 1015.667% |
| Veru Inc. | 4.77 Million USD | -2197.17% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | 1076.383% |
| Cingulate Inc. | 3.08 Million USD | -3461.962% |
| Passage Bio, Inc. | 4.58 Million USD | -2294.853% |
| Context Therapeutics Inc. | -14.44 Million USD | 859.898% |
| Exicure, Inc. | 5.84 Million USD | -1777.312% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 147.663% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | 377.493% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | -599.79% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | 286.675% |
| Nuvalent, Inc. | -335.38 Million USD | 132.739% |
| ABVC BioPharma, Inc. | 1.73 Million USD | -6231.166% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 247.424% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | 1335.141% |
| OmniAb, Inc. | 9.2 Million USD | -1093.133% |
| Anew Medical, Inc. | 1.43 Million USD | -7565.388% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | -570.282% |
| Lipocine Inc. | -4.75 Million USD | 2409.431% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 199.978% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | -620.924% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 316.751% |
| G1 Therapeutics, Inc. | 24.89 Million USD | -341.122% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | 1733.745% |
| Sage Therapeutics, Inc. | -65.82 Million USD | 266.807% |
| Ocugen, Inc. | -32.52 Million USD | 437.64% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 228.313% |
| Q32 Bio Inc. | -37.94 Million USD | 389.354% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | 17584.713% |
| Alumis Inc. Common Stock | -13.52 Million USD | 911.619% |
| Equillium, Inc. | -22.39 Million USD | 590.372% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | 529.459% |
| Coya Therapeutics, Inc. | -32.62 Million USD | 436.546% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | 44390.987% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 18.082% |
| Evelo Biosciences, Inc. | 3.19 Million USD | -3333.521% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | -33331.88% |
| Dominari Holdings Inc. | 195 Thousand USD | -56209.744% |
| Edesa Biotech, Inc. | -5.26 Million USD | 2184.79% |
| vTv Therapeutics Inc. | -8.91 Million USD | 1331.401% |
| Bio-Techne Corporation | 267.74 Million USD | 58.99% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | 777.426% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 192.98% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | 1406.724% |
| Candel Therapeutics, Inc. | -12.65 Million USD | 967.947% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 144.796% |
| Nkarta, Inc. | 57.29 Million USD | -91.633% |
| BioCardia, Inc. | 212 Thousand USD | -51694.34% |
| Iterum Therapeutics plc | 13.43 Million USD | -717.116% |